tiprankstipranks
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
US Market

Jazz Pharmaceuticals (JAZZ) Ownership - Who Owns Jazz Pharmaceuticals?

Compare
1,550 Followers

Jazz Pharmaceuticals (JAZZ) Ownership Overview

3.31%26.42%35.10%27.51%7.65%
35.10% Other Institutional Investors
27.51% ETFs
7.65% Public Companies and Individual Investors
The ownership structure of Jazz Pharmaceuticals (JAZZ) stock is a mix of institutional, retail, and individual investors. Approximately 89.03% of the company’s stock is owned by Institutional Investors, 3.31% is owned by Insiders, and 7.65% is owned by Public Companies and Individual Investors.
The ownership structure of Jazz Pharmaceuticals (JAZZ) stock is a mix of institutional, retail, and individual investors. Approximately 61.52% of the company’s stock is owned by Institutional Investors, 3.31% is owned by Insiders, and 27.51% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 11, 2024
xxxxxxxxxxxxx
$152703
May 07, 2024
Neena M Patil
Evp & Clo
xxxxxxxxxxxxx
$548250
Mar 08, 2024
Patricia Carr
Svp & Cao
xxxxxxxxxxxxx
$438448
Mar 05, 2024
Philip L Johnson
Evp & Chief Financial Officer
xxxxxxxxxxxxx
$1435800

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$5295
Dec 31, 2024
xxxxxxxxxxxxx
$133723659

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,531,845Institution9.15%741,045,956
5,393,792Institution8.92%722,552,376
5,230,345Institution8.65%700,657,016
2,213,587Institution3.66%296,532,115
1,799,347Institution2.98%241,040,524
1,274,248Institution2.11%170,698,262
1,176,106Insider1.95%157,551,160
1,085,860Institution1.80%145,461,806
1,056,729Institution1.75%141,559,417
924,998Institution1.53%123,912,732

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,230,345Institution8.65%700,657,016
1,799,347Institution2.98%241,040,524
924,998Institution1.53%123,912,732
855,847Institution1.42%114,649,264
619,571Institution1.02%82,997,731
595,340Institution0.98%79,751,746
410,082Institution0.68%54,934,585
370,429Institution0.61%49,622,669
348,109Institution0.58%46,632,682
322,684Institution0.53%43,226,749

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,148,190Institution3.55%293,915,356
1,955,920Institution3.24%270,816,683
1,955,852Institution3.24%267,599,671
1,789,465Institution2.96%220,372,615
1,462,529Institution2.42%180,110,446
970,983Institution1.61%119,576,556
917,120Institution1.52%112,943,328
492,502Institution0.81%67,384,124
355,214Institution0.59%47,584,467
257,998Institution0.43%35,299,286

FAQ

Who Owns Jazz Pharmaceuticals (JAZZ)?
According to the latest TipRanks data, approximately 35.10% of the company's stock is held by institutional investors, 3.31% is held by insiders, and 7.65% is held by retail investors.
    What percentage of Jazz Pharmaceuticals (JAZZ) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 35.10% of Jazz Pharmaceuticals (JAZZ) stock is held by institutional investors.
      What percentage of Jazz Pharmaceuticals (JAZZ) stock is held by retail investors?
      According to the latest TipRanks data, approximately 7.65% of Jazz Pharmaceuticals (JAZZ) stock is held by retail investors.
        Who owns the most shares of Jazz Pharmaceuticals (JAZZ)?
        Vanguard owns the most shares of Jazz Pharmaceuticals (JAZZ).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis